Heads we win, tails you lose

February, 3, 2012 | 3 Comments

Comments

  1. The obvious problem is the conflict of interest. As long as drug companies are the ones who get to design studies about the efficacy and safety of their own drugs, the incentive to skew results will be irresistible. This situation is further complicated by the fact that it is legal for drug companies to bribe prominent physicians in various ways to convince their fellow professionals of the stories the drug companies want told. Partial, after-the-fact disclosure of payments taken for ghostwriting, speaking at conferences etc is not good enough. Bribery is illegal in most business contexts and eveyone understands why. Drug companies should not be in a position to convince the public that drugs are safe, when they are not.

  2. “Drug companies should not be in a position to convince the public that drugs are safe, when they are not.”
    Medicine VS drugs who gets to prescribe, and who is ill/who defines illness?
    Voluntary drugs, VS involuntary drug use.
    Who enforces mental health?

    Replace the word “beer” for the word “drug”.

    Beer companies should not be in a position to convince the public that beer (ads on TV) is safe, when beer is not safe.

  3. Profit motive destroys everything. Any company’s goal is profit, and regardless of the industry, that drive for profit demands exploitation. The real question is whether business can be married to anything but greed. Seems the answer is no.

Leave a Reply